Premium
Carthami flos extract and its component, stigmasterol, inhibit tumour promotion in mouse skin two‐stage carcinogenesis
Author(s) -
Kasahara Yoshimasa,
Kumaki Kunio,
Katagiri Susumu,
Yasukawa Ken,
Yamanouchi Sakae,
Takido Michio,
Akihisa Toshihiro,
Tamura Toshitake
Publication year - 1994
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2650080603
Subject(s) - stigmasterol , flos , carthamus , sterol , traditional medicine , tumor promotion , phytotherapy , silybum marianum , flavonoid , carcinogenesis , pharmacognosy , biology , botany , chemistry , biochemistry , biological activity , cholesterol , medicine , antioxidant , chromatography , in vitro , pathology , rutin , gene , alternative medicine
An antitumour‐promoting activity in two‐stage carcinogenesis, is found in the methanol extract of the Carthami Flos ( Carthamus tinctorius L.; Compositae), which is a traditional Chinese medicine and natural pigment of rouge additivies in certain Asian countries. From these active fractions, δ 5 ‐ and δ 7 ‐sterol fractions were separated. The separation was examined for inhibitory activity against TPA‐induced inflammatory ear oedema in mice. Stigmasterol (71% in the mixture) was the most abundant of 14 sterols identified in the δ 5 ‐sterol fraction. Schottenol (70% in the mixture) constituted the dominant sterol of the δ 7 ‐sterol fraction. Furthermore, stigmasterol markedly inhibited tumour promotion in two‐stage carcinogenesis experiments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom